First Time Loading...

OptiBiotix Health PLC
LSE:OPTI

Watchlist Manager
OptiBiotix Health PLC Logo
OptiBiotix Health PLC
LSE:OPTI
Watchlist
Price: 18 GBX
Updated: May 15, 2024

OptiBiotix Health PLC
Cost of Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

OptiBiotix Health PLC
Cost of Revenue Peer Comparison

Comparables:
CNTA
AUTL
BCYC
IMCR
GNS

Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors

Company Cost of Revenue CAGR 3Y CAGR 5Y CAGR 10Y
OptiBiotix Health PLC
LSE:OPTI
Cost of Revenue
-£349.3k
CAGR 3-Years
24%
CAGR 5-Years
-35%
CAGR 10-Years
N/A
Centessa Pharmaceuticals PLC
NASDAQ:CNTA
Cost of Revenue
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Autolus Therapeutics PLC
NASDAQ:AUTL
Cost of Revenue
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Bicycle Therapeutics PLC
NASDAQ:BCYC
Cost of Revenue
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Immunocore Holdings PLC
NASDAQ:IMCR
Cost of Revenue
-£1m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Genus PLC
LSE:GNS
Cost of Revenue
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is OptiBiotix Health PLC's Cost of Revenue?
Cost of Revenue
-349.3k GBP

Based on the financial report for Jun 30, 2023, OptiBiotix Health PLC's Cost of Revenue amounts to -349.3k GBP.

What is OptiBiotix Health PLC's Cost of Revenue growth rate?
Cost of Revenue CAGR 5Y
-35%

Over the last year, the Cost of Revenue growth was 56%. The average annual Cost of Revenue growth rates for OptiBiotix Health PLC have been 24% over the past three years , -35% over the past five years .